ReviewDiagnostic cytopathology2026
Practice of Cytopathology in Korea: A 40-Year Evolution Through Standardization, Digital Transformation, and Global Partnership.
Review in Diagnostic cytopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Asian Federation of Cytology Societies: Origins, Inaugural Congress, and the Enduring Value of In-Person Collaboration in Cytopathology.Diagnostic cytopathology · 2026Article
- Diagnostic concordance of remote WSI-based thyroid cytology compared to conventional cytological diagnosis: a pilot study.Diagnostic pathology · 2026Article
- Practice of Cytopathology in Korea: A 40-Year Evolution Through Standardization, Digital Transformation, and Global Partnership.Diagnostic cytopathology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over four decades, Korea has advanced from a limited cytology service to a global model of digital and AI-integrated cytopathology. Since the founding of the Korean Society for Cytopathology (KSC) in 1986, a nationwide framework has been established-encompassing standardized practices, systematic education for specialists and cytotechnologists, and nationwide cervical screening through the National Cancer Control Program. A mandatory Quality Assurance Program (QAP) launched in 2005 ensured consistent diagnostic quality, achieving an unsatisfactory Pap test rate below 0.2% and cytology-histology discrepancy under 0.6% among over 10 million annual examinations. The 2021 STANBAI project digitized two decades of QAP slides into a standardized whole-slide image (WSI) archive, driving the development of multiple AI models. In parallel, the CytoAcademy web/mobile platform enabled interactive WSI-based education and global participation by over 200 institutions. Korea has also shared this model internationally through on-site and virtual programs in low-resource countries. By integrating national QA, digital infrastructure, AI innovation, and global training, Korea has built a future-ready cytopathology ecosystem-enhancing diagnostic precision and offering a scalable blueprint for global implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.